Taiwan FDA registration 4cb37402a673ee6ef934e45793eb9f11
Billicon 4-in-1 test system
TW: 必立康四合一測試系統
Taiwan·Risk Class 2·APEX BIOTECHNOLOGY CORPORATION·Registered Aug 19, 2020 – Aug 19, 2025ExpiredRegistration details
- Analysis ID
- 4cb37402a673ee6ef934e45793eb9f11
Company information
- Manufacturer
- APEX BIOTECHNOLOGY CORPORATION
- Manufacturer Country
- Taiwan, Province of China
- Authorized Representative
- APEX BIOTECHNOLOGY CORPORATION
Product details
- Intended Use
- This product is an in vitro diagnostic medical device, which is used to quantitatively detect the blood glucose value of whole blood collected from fingertips, palms and arms, and detect cholesterol value, triglyceride value and uric acid value of fingertip blood, which can be used by medical personnel or self-in in vitro testing.
- Product Type (Level 1)
- A Clinical chemistry and clinical toxicology
- Product Type (Level 2)
- A.1775 Uric acid testing system;; A.1705 Triglyceride test system;; A.1175 Cholesterol (Total) Testing System
- Import Information
- QMS/QSD;; 國產
Dates and status
- Registration Date
- Aug 19, 2020
- Expiry Date
- Aug 19, 2025
About this record
Access comprehensive regulatory information for Billicon 4-in-1 test system in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 2 medical device is registered under number 4cb37402a673ee6ef934e45793eb9f11 and manufactured by APEX BIOTECHNOLOGY CORPORATION. The authorized representative in Taiwan is APEX BIOTECHNOLOGY CORPORATION.
This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.
Free DatabasePowered by Pure Global AI89,000+ Devices